The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience

P Gisondi¹, P Facheris^{2

3}, P Dapavo⁴, S Piaserico⁵, A Conti⁶, L Naldi^{7

8}, S Cazzaniga^{8

9}, P Malagoli¹⁰, A Costanzo²

Affiliations

¹ Department of Medicine, Section of Dermatology and Venereology, University of Verona, Italy.
² Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
³ Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
⁴ Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy.
⁵ Section of Dermatology, Department of Medicine, University of Padua, Padova, Italy.
⁶ Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy.
⁷ Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.
⁸ Centro Studi GISED, Bergamo, Italy.
⁹ Department of Dermatology, Inselspital University Hospital of Bern, Bern, Switzerland.
¹⁰ Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy.

Observational Study

P Gisondi et al. Br J Dermatol. 2020 Aug.

. 2020 Aug;183(2):373-374.

doi: 10.1111/bjd.19158. Epub 2020 May 28.

P Gisondi¹, P Facheris^{2

3}, P Dapavo⁴, S Piaserico⁵, A Conti⁶, L Naldi^{7

8}, S Cazzaniga^{8

9}, P Malagoli¹⁰, A Costanzo²

¹ Department of Medicine, Section of Dermatology and Venereology, University of Verona, Italy.
² Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
³ Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.
⁴ Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, Turin, Italy.
⁵ Section of Dermatology, Department of Medicine, University of Padua, Padova, Italy.
⁶ Department of Surgical, Medical, Dental and Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy.
⁷ Department of Dermatology, San Bortolo Hospital, Vicenza, Italy.
⁸ Centro Studi GISED, Bergamo, Italy.
⁹ Department of Dermatology, Inselspital University Hospital of Bern, Bern, Switzerland.
¹⁰ Dermatology Unit, Azienda Ospedaliera San Donato Milanese, Milan, Italy.

No abstract available

Comment in

Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.
Magnano M, Balestri R, Bardazzi F, Mazzatenta C, Girardelli CR, Rech G. Magnano M, et al. Dermatol Ther. 2020 Jul;33(4):e13706. doi: 10.1111/dth.13706. Epub 2020 Jun 19. Dermatol Ther. 2020. PMID: 32475056 Free PMC article. No abstract available.

1. Callaway E. Time to use the p‐word? Coronavirus enter dangerous new phase. Nature 2020; 579:12. - PubMed
1. European Centre for Disease Prevention and Control. Situation update for the EU/EEA and the UK. Available at: https://www.ecdc.europa.eu/en/cases-2019-ncov-eueea (last accessed 2 April 2020).
1. D'Antiga L. Coronaviruses and immunosuppressed patients. The facts during the third epidemic. Liver Transpl 2020; 10.1002/It.25756. - DOI - PubMed
1. Lebwohl M, Rivera‐Oyola R1, Murrell DF. Should biologics for psoriasis be interrupted in the era of COVID‐19? J Am Acad Dermatol 2020; 82:1217–18. - PMC - PubMed
1. American Academy of Dermatology. Guidance on the use of biologic agents during COVID‐19 outbreak. Available at: https://www.aad.org/member/practice/managing/coronavirus (last accessed 2 April 2020).